Lifecycle
Announced
stage pending
Spin-off detail
Catalyst Crew Technologies Corp. -> SpinCo
CCTC / TO ยท detected 2026-02-25
Triage
Monitor
MONITOR
Confidence
49%
detection/extraction
Listing
n/a
distribution n/a
Extracted thesis
The acquisition of the Acquired Assets represents a material transaction for the Company and results in a change in the Company’s business focus from that previously disclosed.
Gaudet was the Company’s majority shareholder.
Levy became the Company’s majority shareholder.
Disease-Focused Modules  
The Company’s artificial intelligence platform includes disease-focused analytical modules currently under development.
PulmoAI is intended to provide pulmonary-focused analytics, including early lung anomaly detection modeling, chronic obstructive pulmonary disease progression forecasting, and imaging analysis relating to pneumonia and pulmonary fibrosis.
Risk flags
Operational dependency flags: related_party_agreements.
risk
Estimated float is unavailable from current filing data.
risk
Source Links
3-Year Financials
Revenue by year
Operating income or ebit by year
Margin by year
Margin trend
Ownership and float
Total shares
Parent retained shares percent
Insider or management shares percent
Restricted or locked up shares
Estimated float percent
Assumption noteFloat estimate unavailable from filing text.
Management incentives
Management ownership percent
Equity comp alignment indicators["CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934  ", "Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  ", "Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  "]
Parent to spinoff leadership migration